These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3204419)

  • 21. Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices.
    Petri M; Spence D; Bone LR; Hochberg MC
    Medicine (Baltimore); 1992 Sep; 71(5):291-302. PubMed ID: 1522805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in cerebrovascular mortality and in its risk factors in Finland during the last 20 years.
    Sarti C; Vartiainen E; Torppa J; Tuomilehto J; Puska P
    Health Rep; 1994; 6(1):196-206. PubMed ID: 7919081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary and secondary prevention of coronary heart disease. Evidence offers multiple strategies.
    Lynn MM
    Adv Nurse Pract; 2000 Jun; 8(6):36-41; quiz 42-3. PubMed ID: 15658206
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention in coronary heart disease.
    Stamler J
    Singapore Med J; 1974 Mar; 15(1):4-24. PubMed ID: 4601891
    [No Abstract]   [Full Text] [Related]  

  • 25. Expected gains in life expectancy from various coronary heart disease risk factor modifications.
    Tsevat J; Weinstein MC; Williams LW; Tosteson AN; Goldman L
    Circulation; 1991 Apr; 83(4):1194-201. PubMed ID: 2013141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2127-30. PubMed ID: 17059084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The biological bases for prevention].
    Paoletti R; Poli A
    G Ital Cardiol; 1989 Sep; 19(9):763-9; discussion 778-86. PubMed ID: 2612822
    [No Abstract]   [Full Text] [Related]  

  • 28. [Preventive measures for practically healthy men of working age].
    Fomina RF; Kozlov ID; Avramenko TV; Apanasevich VV
    Sov Zdravookhr; 1991; (8):44-7. PubMed ID: 1835803
    [No Abstract]   [Full Text] [Related]  

  • 29. The multifactor primary prevention trial in Göteborg, Sweden.
    Wilhelmsen L; Berglund G; Elmfeldt D; Tibblin G; Wedel H; Pennert K; Vedin A; Wilhelmsson C; Werkö L
    Eur Heart J; 1986 Apr; 7(4):279-88. PubMed ID: 3720755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of risk factors and changes in risk factors on coronary mortality in three cohorts of middle-aged people in eastern Finland.
    Jousilahti P; Vartiainen E; Tuomilehto J; Pekkanen J; Puska P
    Am J Epidemiol; 1995 Jan; 141(1):50-60. PubMed ID: 7801966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effectiveness of the cooperative program of multifactorial prevention of ischemic heart disease (results of the 3-year study)].
    Domarkene SB; Baubinene AV; Chazova LV; Kalinina AM; Meĭmanaliev TS; Shleĭfer EA; Davydova LI; Nikolenko EIa; Makhmudov BKh; Karimov TM
    Kardiologiia; 1990 Apr; 30(4):95-8. PubMed ID: 2203931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels.
    Critchley JA; Capewell S
    J Epidemiol Community Health; 2003 Apr; 57(4):243-7. PubMed ID: 12646537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Jones CL; Davis BR; Basile JN; Goff DC; Ciocon JO; Sweeney ME; Randall OS;
    Diabetes Care; 2001 Apr; 24(4):654-8. PubMed ID: 11315826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart.
    Menotti A; Lanti M; Puddu PE; Kromhout D
    Heart; 2000 Sep; 84(3):238-44. PubMed ID: 10956281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Classical risk factors for myocardial infarction and total mortality in the community--13-year follow-up of the MONICA Augsburg cohort study].
    Heidrich J; Wellmann J; Hense HW; Siebert E; Liese AD; Löwel H; Keil U
    Z Kardiol; 2003 Jun; 92(6):445-54. PubMed ID: 12819993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of the major risk factors for coronary heart disease.
    Gotto AM
    Am J Med; 1986 Feb; 80(2A):48-55. PubMed ID: 3946461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring Trends and Determinants in Cardiovascular Diseases.
    Keil U; Liese AD; Hense HW; Filipiak B; Döring A; Stieber J; Löwel H
    Eur Heart J; 1998 Aug; 19(8):1197-207. PubMed ID: 9740341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease.
    Haq IU; Jackson PR; Yeo WW; Ramsay LE
    Lancet; 1995 Dec; 346(8988):1467-71. PubMed ID: 7490996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the benefits of cholesterol lowering: are risk factors for coronary heart disease multiplicative?
    Silberberg JS
    J Clin Epidemiol; 1990; 43(9):875-9. PubMed ID: 2213077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population.
    Antikainen R; Jousilahti P; Tuomilehto J
    J Hypertens; 1998 May; 16(5):577-83. PubMed ID: 9797168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.